Provides an overview of the pathophysiology, clinical presentation, and up-to-date therapeutic management of adult diabetic ketoacidosis.
Answers are grounded in this paper and cite their sources.
Offers DKA management synthesis for clinicians; leaves open prospective trials on emerging therapies.
Diabetic ketoacidosis (DKA) is a rare yet potentially fatal hyperglycemic crisis that can occur in patients with both type 1 and 2 diabetes mellitus. Due to its increasing incidence and economic impact related to the treatment and associated morbidity, effective management and prevention is key. Elements of management include making the appropriate diagnosis using current laboratory tools and clinical criteria and coordinating fluid resuscitation, insulin therapy, and electrolyte replacement through feedback obtained from timely patient monitoring and knowledge of resolution criteria. In addition, awareness of special populations such as patients with renal disease presenting with DKA is important. During the DKA therapy, complications may arise and appropriate strategies to prevent these complications are required. DKA prevention strategies including patient and provider education are important. This review aims to provide a brief overview of DKA from its pathophysiology to clinical presentation with in depth focus on up-to-date therapeutic management.
No takes yet. Share an insight, caveat, or question.
Gosmanov et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: